4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001144204-17-044479
Exec. VP, Corporate Strategy sold 4,976 shares at an average $40.01 ($199,098)
- Exec. VP, Corporate Strategy acquired 4,976 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bendheim Daniel M Exec. VP, Corporate Strategy | 2017-08-17 | Option exercise | +4,176 | $11.83 | $49,402 | 4,176 | D: show line 1 in the form |
| Bendheim Daniel M Exec. VP, Corporate Strategy | 2017-08-17 | Sale | −4,176 | $40.01 | $167,082 | 0 | D: show line 2 in the form |
| Bendheim Daniel M Exec. VP, Corporate Strategy | 2017-08-21 | Option exercise | +800 | $11.83 | $9,464 | 800 | D: show line 3 in the form |
| Bendheim Daniel M Exec. VP, Corporate Strategy | 2017-08-21 | Sale | −800 | $40.02 | $32,016 | 0 | D: show line 4 in the form |
| Open-market sales · 4,976 sh · avg $40.01 · $199,098 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Bendheim Daniel M Exec. VP, Corporate Strategy | 2017-08-17 | Option exercise · Option to purchase Common Stock | −4,176 | 27,923 | D: show line 5 in the form | |||||
| Bendheim Daniel M Exec. VP, Corporate Strategy | 2017-08-21 | Option exercise · Option to purchase Common Stock | −800 | 27,123 | D: show line 6 in the form |
Loading xslF345X03/v473786_form4.xml…